Please use this identifier to cite or link to this item:
|Title:||Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation|
|Source:||Buisson, M.,Fleurent, B.,Mak, M.,Morand, P.,Chan, L.,Ng, A.,Guan, M.,Chin, D.,Seigneurin, J.M. (1999). Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. Journal of Clinical Microbiology 37 (8) : 2709-2714. ScholarBank@NUS Repository.|
|Abstract:||A new immunoblot assay, composed of four Epstein-Barr virus (EBV)- encoded recombinant proteins (virus capsid antigen [VCA] p23, early antigen [EA] p138, EA p54, and EBNA-1 p72), was compared with an immunofluorescence assay on a total of 291 sera. The test was accurate in 94.5% of cases of primary EBV infection, while an immunoglobulin G anti-VCA p23 band with strong intensity correlated with reactivation.|
|Source Title:||Journal of Clinical Microbiology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 17, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.